Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 18, 2008 - Issue 12
Submit an article Journal homepage
51
Views
0
CrossRef citations to date
0
Altmetric
Review

Cancer stem cell patents

Brynn T Kvinlaug University of Cambridge, Cambridge Institute for Medical Research, Department of Haematology, CB2 0XY, Cambridge, UK +44 1223 763368; +44 1223 762670; [email protected]
&
Stanley E Lazic University of Cambridge, Cambridge Computational Biology Institute, Department of Applied Mathematics and Theoretical Physics, CB3 0WA, Cambridge, UK
Pages 1405-1416 | Published online: 18 Nov 2008

Bibliography

  • Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367(6464):645-8
  • Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3(7):730-7
  • Taussig DC, Miraki-Moud F, Anjos-Afonso F, et al. Anti-CD38 antibody-mediated clearance of human repopulating cells mask the heterogeneity of leukemia-initiating cells. Blood 2008;112(3):568-75
  • Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004;5(7):738-43
  • Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100(7):3983-8
  • Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63(18):5821-8
  • Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004;432(7015):396-401
  • Xin L, Lawson DA, Witte ON. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 2005;102(19):6942-7
  • Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65(23):10946-51
  • Lawson DA, Xin L, Lukacs RU, et al. Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 2007;104(1):181-6
  • O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445(7123):106-10
  • Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445(7123):111-5
  • Kim CFB, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121(6):823-35
  • Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67(3):1030-7
  • Kondo T. Methods and means related to cancer stem cells. US2008132423; 2008
  • Sanchez-Garcia I, Perez-Caro M. Identification of cancer stem cells using genetic markers. WO2008029290; 2008
  • Jamieson CH, Geron I, Abrahamson A, et al. WNT pathway mutations in cancer stem cells. WO2008073619; 2008
  • Dick JE. Acute myeloid leukemia stem cells. Ann N Y Acad Sci 2005;1044:1-5
  • Edwards RH, Wasik MA, Finan J, et al. Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia. Am J Clin Pathol 1999;112(6):819-27
  • Asou N. 2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia. Intern Med 2007;46(2):91-3
  • Kazuo U, Masahiro K, Yoji U, Yoko I. Therapeutic agent for ATRA-resistant APL. JP2005068080; 2005
  • George AA, Franklin J, Kerkof K, et al. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia. Blood 2001;97(12):3925-30
  • Hong D, Gupta R, Ancliff P, et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 2008;319(5861):336-9
  • Nilsson L, Astrand-Grundstrom I, Anderson K, et al. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 2002;100(1):259-67
  • Kong Y, Yoshida S, Saito Y, et al. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia 2008;22(6):1207-13
  • Szatrowski TP, Dodge RK, Reynolds C, et al. Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311. Cancer 2003;97(6):1471-80
  • Cortes J, O'Brien S, Kantarjian H. Discontinuation of imatinib therapy after achieving a molecular response. Blood 2004;104(7):2204-5
  • Graham SM, Jorgensen HG, Allan E et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro Blood 2002;99(1):319-25
  • Holtz MS, Slovak ML. Zhang F, et al. Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation. Blood 2002;99(10):3792-800
  • Bandyopadhyay S, Pal BC, Bhattacharya S, et al. A pharmaceutical composition useful for treating chronic myeloid leukemia. WO2004004708; 2004
  • Braun K, Waldeck W, Pipkorn R, et al. PNA-conjugates for treating chronic myeloid leukemia (CML). WO03039438; 2003
  • Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood 2004;103(6):2332-6
  • Matsui W, Wang Q, Barber JP, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 2008;68(1):190-7
  • Peacock CD, Wang Q, Gesell GS, et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 2007;104(10):4048-53
  • Austad B, Janardanannair S, Lescarbeau A, et al. Methods of use for cyclopamine analogs. WO2008083252; 2008
  • Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007;67(9):4010-5
  • Wang J, Sakariassen PO, Tsinkalovsky O, et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 2008;122(4):761-8
  • Liu G, Yuan X, Zeng Z, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006;5:67
  • Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444(7120):756-60
  • Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005;307(5717):1904-9
  • Marchiano RD. Digestive system cancer stem cells and tests and uses therefor. WO2008034645; 2008
  • Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118(6):2111-20
  • Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007;104(24):10158-63
  • Giangreco A, Groot KR, Janes SM. Lung cancer and lung stem cells: Strange bedfellows? Am J Respir Crit Care Med 2007;175(6):547-53
  • Berns A. Stem cells for lung cancer? Cell 2005;121(6):811-3
  • Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008;15(3):504-14
  • Dontu G, El-Ashry D, Wicha MS. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab 2004;15(5):193-7
  • Ponti D, Zaffaroni N, Capelli C, Daidone MG. Breast cancer stem cells: an overview. Eur J Cancer 2006;42(9):1219-24
  • Clarke MG, Morrison SJ, Wicha MA, Al-Hajj M. Isolation and use of solid tumor stem cells. US2007231325; 2003
  • Honeth G, Bendahl PO, Ringner M, et al. The CD44+/CD24- phenotype is enriched in basal-like breast tumors [abstract]. Breast Cancer Res 2008;10(3):R53
  • Collins AT, Maitland NJ. Prostate cancer stem cells. Eur J Cancer 2006;42(9):1213-8
  • Burger PE, Xiong X, Coetzee S, et al. Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci USA 2005;102(20):7180-5
  • Collins AT, Habib FK, Maitland NJ, Neal DE. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 2001;114:3865-72
  • Richardson GD, Robson CN, Lang SH et al. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004 117(Pt 16):3539-45
  • Maitland N, Collins A. Prostate stem cell. WO2005089043; 2005
  • Patrawala L, Calhoun T, Schneider-Broussard R, et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006;25(12):1696-708
  • Li JG. Liver-cancer stem cell, its separation and use. CN1940062; 2007
  • Ma S, Chan KW, Lee TK, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008;6(7):1146-53
  • Wicha M, Dontu G, Ginestier C, et al. Aldehyde dehydrogenase 1(ALDH1) as a cancer stem cell marker. WO2008036419; 2008
  • Yang ZF, Ho DW, Ng MN, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008;13(2):153-66
  • Monzani E, Facchetti F, Galmozzi E. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumorigenic potential. Eur J Cancer 2007;43(5):935-46
  • Dou J, Pan M, Wen P, et al. Isolation and identification of cancer stem-like cells from murine melanoma cell lines. Cell Mol Immunol 2007;4(6):467-72
  • Holyoake T, Jiang X, Eaves C, Eaves A. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 1999;94(6):2056-64
  • Zhang Y, Zhou J, Zhang H. Use of 8-quinolinol and its analogs to target cancer stem cells. WO2008013966; 2008
  • Raaijmakers MH, de Grouw EP, Heuver LH, et al. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia. Clin Cancer Res 2005;11(6):2436-44
  • Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating human melanomas. Nature 2008;451(7176):345-9
  • Shervington A, Lu C. Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Invest 2008;26(5):535-42
  • Sung JM, Cho HJ, Yi H, et al. Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun 2008;371(1):163-7
  • Christgen M, Ballmaier M, Bruchhardt H, et al. Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Mol Cell Biochem 2007;306:201-12
  • Olempska M, Eisenach PA, Ammerpohl O, et al. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Hepatobiliary Pancreat Dis Int 2007;6(1):92-7
  • Pascal LE, Oudes AJ, Petersen TW, et al. Molecular and cellular characterization of ABCG2 in the prostate. BMC Urol 2007;7:6
  • Donnenberg VS, Donnenberg AD. Identification of a constitutively resistant cancer stem cell. WO2007118242; 2007
  • Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct ‘side population’ of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004;101(39):14228-33
  • Mitsutake N, Iwao A, Nagai K, et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 2007;148(4):1797-803
  • Huang D, Gao Q, Guo L. Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev 2008 [Epub ahead of print]
  • Smyth MJ, Krasovskis E, Sutton VR, Johnstone RW. The drug efflux protein, p-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci USA 1998;95(12):7024-9
  • Johnstone RW, Cretney E, Smyth MJ. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 1999;93(3):1075-85
  • van Stijn A, van der Pol MA, Kok A, et al. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia. Haematologica 2003;88(5):497-508
  • Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444(7120):687-8
  • Blazek ER, Foutch JL, Maki G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys 2007;67(1):1-5
  • Kang MK, Hur BI, Ko MH, et al. Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma. BMC Neurosci 2008;9:15
  • Kawabe T, Kobayashi H. Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments. US2008227827; 2008
  • Jin L, Hope KJ, Zhai Q, et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006;12(10):1167-74
  • Charrad RS, Gadhoum Z, Qi J, et al. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 2002;99(1):290-9
  • Charrad RS, Li Y, Delpech B, et al. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med 1999;5(6):669-76
  • Krause DS, Lazarides K, von Andrian UH, Etten RAV. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 2006;12(10):1175-80
  • Smadja F, Dick JE, Kadouche J. Chimeric anti-CD44 antibodies and their use for treating acute myeloid leukemia. US2007237761; 2007
  • Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001;98(8):2301-7
  • Guzman ML, Swiderski CF, Howard DS, et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci USA 2002;99(25):16220-5
  • Guzman ML, Rossi RM, Karnischky L, et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005;105(11):4163-9
  • Crooks PA, Jordan CT, Wei X. Use of parthenolide derivatives as antileukemic and cytotoxic agents. US2005272716; 2005
  • Konopleva M, Contractor R, Tsao T, et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 2006;10(5):375-88
  • Yu Q, Tan J, Yang XJ. Methods for cancer therapy and stem cell modulation. WO2007100304; 2007
  • Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006;66(9):4553-7
  • Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007;11(1):69-82
  • Huntly BJP, Shigematsu H, Deguchi K, et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004;6(6):587-96
  • Cozzio A, Passegue E, Ayton PM, et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003;17(24):3029-35
  • Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007;26:6766-76
  • Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003;423(6937):255-60
  • Liu S, Dontu G, Mantle ID, et al. Hedgehog signaling and bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006;66(12):6063-71
  • Malanchi I, Peinado H, Kassen D, et al. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 2008;452(7187):650-3
  • Yilmaz OH, Valdez R, Theisen BK, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006;441(7092):475-82
  • Zhang J, Grindley JC, Yin T, et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006;441:518-22
  • Krivtsov AV, Twomey D, Feng Z, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006;442(7104):818-22
  • Krivtsov AV, Armstrong S. Novel signature self renewal gene expression programs. WO2007112097; 2007
  • Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002;30(1):41-7
  • Murat A, Migliavacca E, Gorlia T, et al. Stem cell-related ‘self-renewal’ signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008;26(18):3015-24
  • Birnie R, Bryce SD, Roome C, et al. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biology 2008;9:R83
  • Liu R, Wang X, Chen GY, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007;356(3):217-26
  • Jordan CT, Guzman ML, Hassane D. Use of gene signatures to design novel cancer treatment regimens. WO2008086182; 2008
  • Donnenberg VS, Donnenberg AD. Identification of a constitutively resistant cancer stem cell. WO2007118242; 2007
  • Kato J. Method for producing and acquiring cancer stem cell and method for screening antileukemic medicine by targeting the same stem cell. JP2007330205; 2007
  • Takakura N, Yamada Y, Kidoya H. Method of producing cancer stem cell. WO2006115243; 2006
  • Sanchez-Garcia I, Voces SF. Murine stem cells and applications thereof. EP1726208; 2006
  • Robins AJ, Schulz TC. Human cancer stem cell culture compositions comprising ERBB2 variants and methods of use thereof. WO2007147165; 2007
  • Scheffler B, Goetz AK, Steindler DA. Isolation, expansion and uses of tumor stem cells. WO2008033393; 2008
  • Mazar A. Antibodies to urokinase-type plasminogen activator receptor (uPAR) bind cancer stem cells: use in diagnosis and therapy. WO2007134274; 2007
  • Reiter R, Witte O. PSCA: Prostate stem cell antigen for diagnosis and treatment of prostate cancer. NZ516660; 2003
  • Donnenberg VS, Donnenberg AD. constitutively resistant cancer stem cells in diagnosis. WO2007118238; 2007
  • Laird P, Widschwendter M. DNA methylation markers based on epigenetic stem cell signatures in cancer. WO2008083251; 2008
  • Cirrito T, Bergstein I. Cancer therapy with cantharidin and cantharidin analogs. WO2008030617; 2008
  • Cirrito T, Bergstein I. Cancer stem cell-targeted cancer therapy. WO2008030538; 2008
  • Yu J. Cancer stem cell antigen vaccines and methods. WO2008039874; 2008
  • Gurney A, Sato A, Fitch-Bruhns M. Compositions and methods for diagnosing and treating cancer. WO2008091641; 2008
  • Lewicki J, Gurney A, Satyal S. Compositions and methods for diagnosing and treating cancer. WO2008070090; 2008
  • Philip R, Keller LH. Immunogens in cancer stem cells. WO2008070047; 2008
  • Yu Q, Tan J, Yang XJ. Methods for cancer therapy and stem cell modulation. WO2007100304; 2007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.